Botanix Pharmaceuticals is an ASX-listed pharmaceutical company developing and commercialising dermatology and antimicrobial treatments based on synthetic cannabinoids. Its lead product, Sofdra (sofpironium) topical gel, is FDA-approved and available in the United States, while the company’s experienced dermatology team advances treatments for underserved skin diseases and infections. Botanix operates across Australia and the United States, with commercial operations being built in Phoenix.
FDA Approval
Compliance program
Alphyn BiologicsFounded by a team led by the scientist who helped develop Bactroban, Alphyn Biologics is a clinical-stage dermatology company developing topical medicines for difficult skin diseases. Based in Annapolis and Cincinnati, the company’s botanical Zabalafin Platform uses multiple bioactive compounds to address several disease drivers at once, with lead programs targeting atopic dermatitis and molluscum contagiosum. Alphyn became operational in 2020 and has wholly owned subsidiaries in Australia and Austria.
Topix Pharmaceuticals, IncSince 1981, Topix Pharmaceuticals has developed medical-grade, practice-branded skincare for dermatologists, physicians and skin-care professionals worldwide. Its pharmaceutical-minded formulas use purified active ingredients, proprietary delivery systems and research published in peer-reviewed medical literature, with the company’s work in green tea polyphenols standing out as a particular specialty. Topix also helps practices create and support customized skincare lines, manufacturing them at an FDA-registered facility.WEST BABYLON, NY
Velius, LLCVelius, LLC is a research-driven biopharmaceutical company developing prescription and over-the-counter medicines that target or are delivered through the skin. Founded and built by medical professionals, the Great Neck company is led by a surgeon and a pharmacist and has built its portfolio around nanotechnology-enabled film delivery, including products for scar treatment and dermatological conditions. Its intellectual-property portfolio includes patents issued in more than 25 countries and a suite of 19 developed pharmaceuticals.GREAT NECK, NY
ESSENTIAL REMEDIUM® & ER Scientific™Essential Remedium® & ER Scientific™ is a New York research-driven life-science and early-stage pharmaceutical company developing affordable treatments for unmet medical needs. Its portfolio includes products such as DandrOheal® for dandruff and seborrheic dermatitis and MastOnorm®, a botanical oral treatment for fibrocystic breast disease, supported by completed clinical studies. The company also develops a targeted DS-T1 delivery system for topical therapies, designed to stabilize active ingredients while directing them to affected tissue.NEW YORK, NY